452 related articles for article (PubMed ID: 10463983)
21. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens.
Pettaway CA; Troncoso P; Ramirez EI; Johnston DA; Steelhammer L; Babaian RJ
J Urol; 1998 Aug; 160(2):437-42. PubMed ID: 9679893
[TBL] [Abstract][Full Text] [Related]
22. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
Abdalla I; Ray P; Vaida F; Vijayakumar S
Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
[TBL] [Abstract][Full Text] [Related]
23. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
24. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
[TBL] [Abstract][Full Text] [Related]
25. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.
Moul JW; Connelly RR; Mooneyhan RM; Zhang W; Sesterhenn IA; Mostofi FK; McLeod DG
J Urol; 1999 Aug; 162(2):394-7. PubMed ID: 10411045
[TBL] [Abstract][Full Text] [Related]
26. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418
[TBL] [Abstract][Full Text] [Related]
27. Racial differences in operating characteristics of prostate cancer screening tests.
Smith DS; Bullock AD; Catalona WJ
J Urol; 1997 Nov; 158(5):1861-5; discussion 1865-6. PubMed ID: 9334618
[TBL] [Abstract][Full Text] [Related]
28. Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.
Preston MA; Gerke T; Carlsson SV; Signorello L; Sjoberg DD; Markt SC; Kibel AS; Trinh QD; Steinwandel M; Blot W; Vickers AJ; Lilja H; Mucci LA; Wilson KM
Eur Urol; 2019 Mar; 75(3):399-407. PubMed ID: 30237027
[TBL] [Abstract][Full Text] [Related]
29. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer.
Asbell SO; Vijayakumar S
Prostate; 1997 Apr; 31(1):42-6. PubMed ID: 9108885
[TBL] [Abstract][Full Text] [Related]
30. Association between prediagnostic prostate-specific antigen and prostate cancer probability in Black and non-Hispanic White men.
Lee KM; Bryant AK; Lynch JA; Robison B; Alba PR; Agiri FY; Pridgen KM; DuVall SL; Yamoah K; Garraway IP; Rose BS
Cancer; 2024 Jan; 130(2):224-231. PubMed ID: 37927109
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer stage shift has eliminated the gap in disease-free survival in black and white American men after radical prostatectomy.
Bianco FJ; Wood DP; Grignon DJ; Sakr WA; Pontes JE; Powell IJ
J Urol; 2002 Aug; 168(2):479-82. PubMed ID: 12131292
[TBL] [Abstract][Full Text] [Related]
32. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.
Latchamsetty KC; Kim J; Porter CR
J Urol; 2006 Mar; 175(3 Pt 1):913-7; discussion 917. PubMed ID: 16469578
[TBL] [Abstract][Full Text] [Related]
33. Prostate specific antigen in black and white men after hormonal therapies for prostate cancer.
Fowler JE; Bigler SA; Renfroe DL; Dabagia MD
J Urol; 1997 Jul; 158(1):150-4. PubMed ID: 9186343
[TBL] [Abstract][Full Text] [Related]
34. Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer.
Eastham JA; May RA; Whatley T; Crow A; Venable DD; Sartor O
J Natl Cancer Inst; 1998 May; 90(10):756-60. PubMed ID: 9605645
[TBL] [Abstract][Full Text] [Related]
35. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
[TBL] [Abstract][Full Text] [Related]
36. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer in patients with screening serum prostate specific antigen values less than 4.0 ng/dl: results from the cooperative prostate cancer tissue resource.
Datta MW; Dhir R; Dobbin K; Bosland MC; Melamed J; Becich MJ; Orenstein JM; Kajdacsy-Balla AA; Patel A; Macias V; Berman JJ
J Urol; 2005 May; 173(5):1546-51. PubMed ID: 15821483
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease.
Powell IJ; Banerjee M; Novallo M; Sakr W; Grignon D; Wood DP; Pontes JE
Urology; 2000 Feb; 55(2):246-51. PubMed ID: 10688088
[TBL] [Abstract][Full Text] [Related]
39. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.
Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA
BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177
[TBL] [Abstract][Full Text] [Related]
40. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis.
Zeliadt SB; Penson DF; Albertsen PC; Concato J; Etzioni RD
Cancer; 2003 Aug; 98(3):496-503. PubMed ID: 12879465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
